These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8001029)

  • 1. Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck.
    Yasumura S; Amoscato A; Hirabayashi H; Lin WC; Whiteside TL
    Cancer Immunol Immunother; 1994 Dec; 39(6):407-15. PubMed ID: 8001029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
    Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.
    Posner MR; Cavacini LA; Upton MP; Tillman KC; Gornstein ER; Norris CM
    Clin Cancer Res; 1999 Aug; 5(8):2261-70. PubMed ID: 10473114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.
    Hald J; Rasmussen N; Claesson MH
    Cancer Immunol Immunother; 1995 Oct; 41(4):243-50. PubMed ID: 7489567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
    Dao T; Holán V; Minowada J
    Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a T-cell-derived mast cell costimulatory activity (MCA) that acts synergistically with interleukin 3 and interleukin 4 on the growth of murine mast cells.
    Schmitt E; Hüls C; Nagel B; Rüde E
    Cytokine; 1990 Nov; 2(6):407-15. PubMed ID: 2104234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
    Wolf JS; Chen Z; Dong G; Sunwoo JB; Bancroft CC; Capo DE; Yeh NT; Mukaida N; Van Waes C
    Clin Cancer Res; 2001 Jun; 7(6):1812-20. PubMed ID: 11410524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
    Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
    J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
    Hoffmann TK; Meidenbauer N; Dworacki G; Kanaya H; Whiteside TL
    Cancer Res; 2000 Jul; 60(13):3542-9. PubMed ID: 10910067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors.
    Bailet JW; Lichtenstein A; Chen G; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):855-62. PubMed ID: 9260552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
    Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.